Table 2.
Patient-reported outcome measures
|
Hip arthroscopy (n=171) |
Personalised hip therapy (n=177) |
Unadjusted difference | Adjusted difference (95% CI) | p value | |||
|---|---|---|---|---|---|---|---|
| Mean (SD) | n | Mean (SD) | n | ||||
| iHOT-33 | |||||||
| 6 months | 46·6 (25) | 161 | 45·6 (23) | 154 | 1·0 | −0·7 (−5·2 to 3·7) | 0·743 |
| 12 months* | 58·8 (27) | 158 | 49·7 (25) | 163 | 9·1 | 6·8 (1·7 to 12·0) | 0·0093 |
| EQ-5D-5L (utility) | |||||||
| 6 months | 0·544 (0·26) | 144 | 0·573 (0·23) | 147 | −0·029 | −0·042 (−0·088 to 0·005) | 0·081 |
| 12 months | 0·615 (0·25) | 152 | 0·578 (0·24) | 147 | 0·037 | 0·020 (−0·027 to 0·067) | 0·397 |
| EQ-5D VAS | |||||||
| 6 months | 67·8 (19·3) | 145 | 70·3 (19·3) | 145 | −2·5 | −2·1 (−5·7 to 1·4) | 0·241 |
| 12 months | 71·9 (20·7) | 150 | 69·2 (19·4) | 145 | 2·7 | 2·6 (−1·2 to 6·4) | 0·180 |
| SF-12 PCS | |||||||
| 6 months | 43·4 (7·0) | 146 | 44·2 (6·6) | 142 | −0·8 | −0·7 (−2·1 to 0·7) | 0·304 |
| 12 months | 45·1 (6·3) | 145 | 44·2 (6·4) | 132 | 1·0 | 1·1 (−0·2 to 2·5) | 0·099 |
| SF-12 MCS | |||||||
| 6 months | 42·1 (7·3) | 146 | 42·1 (7·2) | 142 | −0·1 | −0·1 (−1·5 to 1·3) | 0·929 |
| 12 months | 43·2 (7·1) | 145 | 42·6 (6·9) | 132 | 0·6 | 0·4 (−1·2 to 2·0) | 0·589 |
iHOT-33=International Hip Outcome Tool. VAS=visual analogue score. PCS=physical component score. MCS=mental component score.
*
Primary outcome.